Surgical Science Sweden AB (publ) (STO:SUS)
Sweden · Delayed Price · Currency is SEK 38.20
+0.92 (2.47%)
Aug 14, 2026, 5:29 PM CET
STO:SUS Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 52.21 | 66.82 | 131.65 | 233.97 | 187.97 | 86.25 |
Depreciation & Amortization | 55.42 | 53.78 | 41.36 | 38.4 | 35.66 | 23.9 |
Other Amortization | 29.29 | 29.59 | 19.15 | 17.21 | 15.93 | 9.62 |
Other Operating Activities | 5.07 | -8.7 | 10.95 | -45.64 | -44.46 | -34 |
Change in Accounts Receivable | 33.01 | -87.61 | -20.24 | 31.91 | -70.76 | -84.57 |
Change in Inventory | -3.68 | -16.39 | -11.56 | -19.57 | -21.72 | 6.46 |
Change in Other Net Operating Assets | -21.27 | 42.31 | -34.09 | -17.99 | 26.87 | 31.43 |
Operating Cash Flow | 150.06 | 79.8 | 137.23 | 238.29 | 129.49 | 39.08 |
Operating Cash Flow Growth | 44.59% | -41.85% | -42.41% | 84.03% | 231.31% | 68.28% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -18.88 | -11.68 | -6.1 | -10.46 | -9.35 | -3.87 |
Cash Acquisitions | -0.03 | -84.91 | - | - | - | -2,718 |
Sale (Purchase) of Intangibles | -37.71 | -37.66 | -41.43 | -33.67 | -25.2 | -10.51 |
Investing Cash Flow | -56.63 | -134.25 | -47.53 | -44.13 | -34.55 | -2,733 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | 235.41 | - | 17.09 | - |
Long-Term Debt Repaid | - | -259.72 | -2.23 | -1.26 | - | -31.72 |
Total Debt Repaid | -28.18 | -259.72 | -2.23 | -1.26 | - | -31.72 |
Net Debt Issued (Repaid) | -32.63 | -259.72 | 233.18 | -1.26 | 17.09 | -31.72 |
Issuance of Common Stock | - | - | - | - | - | 3,039 |
Other Financing Activities | 3.52 | 0.05 | -5.53 | 17.11 | - | -84.87 |
Financing Cash Flow | -29.1 | -259.68 | 227.65 | 15.85 | 17.09 | 2,922 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -9.5 | -37.6 | 16.44 | -9.38 | 5.02 | 0.59 |
Net Cash Flow | 54.84 | -351.73 | 333.79 | 200.63 | 117.05 | 229.52 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 131.18 | 68.12 | 131.12 | 227.84 | 120.14 | 35.21 |
Free Cash Flow Growth | 35.37% | -48.05% | -42.45% | 89.65% | 241.18% | 54.26% |
Free Cash Flow Margin | 13.43% | 6.86% | 14.83% | 25.81% | 14.97% | 9.60% |
Free Cash Flow Per Share | 2.57 | 1.33 | 2.57 | 4.47 | 2.36 | 0.82 |
Levered Free Cash Flow | 53.55 | -217.94 | 276.41 | 94.14 | 95.86 | 17.79 |
Unlevered Free Cash Flow | 57.4 | -214.09 | 279.88 | 94.55 | 96.19 | 18.11 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | 42.73 | 49.5 | 27.69 | 14.55 | 8.48 | 3.43 |
Change in Working Capital | 8.06 | -61.7 | -65.89 | -5.65 | -65.61 | -46.69 |